Filing Flows › Caribou Biosciences (CRBU) › Q2 2026 › vs Q1 2026
Caribou Biosciences (CRBU) Q2 2026 vs Q1 2026 (quarter over quarter)
Caribou Biosciences's revenue fell $898K (-37%) from $2.4M in Q1 2026 to $1.5M in Q2 2026.
Caribou Biosciences, Q2 2026: revenue $1.5M (-44% year over year), net loss $24.3M, operating cash flow −$22.8M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.5M | $2.4M | −$898K | -37% |
| Other income, net | $1.1M | $1.2M | −$138K | -12% |
| Net loss | $24.3M | $25.1M | −$803K | -3% |
| Costs & expenses | $26.8M | $28.7M | −$1.8M | -6% |
| Operating costs | $26.8M | $28.7M | −$1.8M | -6% |
| Research & development | $18.9M | $20.6M | −$1.7M | -8% |
| General & admin | $7.9M | $8.1M | −$170K | -2% |
| Operating cash sources | $25.9M | $30.0M | −$4.1M | -14% |
| Depreciation & amortization | $625K | $649K | −$24K | -4% |
| Share-based compensation | $2.5M | $2.4M | $120K | +5% |
| Cash used in operations | $22.8M | $27.0M | −$4.2M | -16% |
| Net loss absorbed | $24.3M | $25.1M | −$803K | -3% |
| Working capital & other | $1.6M | $4.9M | −$3.3M | -67% |
Questions
How much did Caribou Biosciences's revenue grow quarter over quarter in Q2 2026?
Caribou Biosciences's revenue fell $898K (-37%) from $2.4M in Q1 2026 to $1.5M in Q2 2026.